Novozymes, a long time player in industrial enzyme applications, has launched a consumer facing health division that becomes an instant heavy hitter in the category. The head of the division gave NutraIngredients-USA a peek behind the curtain.
Denmark’s Novozymes is bringing its human health growth platform Novozymes OneHealth to the US market, offering a range of clinically supported ingredients developed in response to “profound health challenges related to modern lifestyles”.
Intoleran, a Dutch dietary enzymes brand, has launched its line of finished dietary supplements into the US on Amazon, including a flagship formula that the company claims helps address an underlying issue for those suffering from gluten intolerance.
Enzymit, an Israeli development state company, has secured $5 million in funding to further develop its AI platform that can greatly speed the development of novel enzymes. The technology has the potential to cut the cost of many ingredients now made...
Virginia-based Bio-Cat, Inc. is sponsoring a clinical trial at the University of Illinois at Urbana-Champaign to investigate the efficacy of a digestive enzyme blend designed to improve protein digestion and gastrointestinal tolerance.
Ingredients giant DSM has teamed up with San Diego-based startup Debut Biotech to explore the potential of its ‘cell-free’ biomanufacturing platform, a next-generation manufacturing process it claims could unlock new opportunities to biosynthesize a far...
The US enzyme market is set for healthy growth, according to a new
report, but continued downward pricing pressures mean that this
growth will likely result from a corresponding increase in food and